- Home
- SNWV vs CYRX Comparison
SNWV vs CYRX Comparison
Compare SNWV & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNWV
- CYRX
- Stock Information
- Founded
- SNWV 2004
- CYRX 1999
- Country
- SNWV United States
- CYRX United States
- Employees
- SNWV N/A
- CYRX N/A
- Industry
- SNWV
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- SNWV
- CYRX Health Care
- Exchange
- SNWV NYSE
- CYRX Nasdaq
- Market Cap
- SNWV 309.9M
- CYRX 365.5M
- IPO Year
- SNWV N/A
- CYRX N/A
- Fundamental
- Price
- SNWV $36.24
- CYRX $7.27
- Analyst Decision
- SNWV Strong Buy
- CYRX Strong Buy
- Analyst Count
- SNWV 1
- CYRX 10
- Target Price
- SNWV $49.00
- CYRX $10.90
- AVG Volume (30 Days)
- SNWV 57.2K
- CYRX 432.7K
- Earning Date
- SNWV 08-11-2025
- CYRX 08-05-2025
- Dividend Yield
- SNWV N/A
- CYRX N/A
- EPS Growth
- SNWV N/A
- CYRX N/A
- EPS
- SNWV N/A
- CYRX N/A
- Revenue
- SNWV $36,190,000.00
- CYRX $232,134,000.00
- Revenue This Year
- SNWV N/A
- CYRX N/A
- Revenue Next Year
- SNWV N/A
- CYRX $9.36
- P/E Ratio
- SNWV N/A
- CYRX N/A
- Revenue Growth
- SNWV 61.50
- CYRX 11.75
- 52 Week Low
- SNWV $5.21
- CYRX $4.58
- 52 Week High
- SNWV $39.83
- CYRX $9.66
- Technical
- Relative Strength Index (RSI)
- SNWV N/A
- CYRX 48.45
- Support Level
- SNWV N/A
- CYRX $6.70
- Resistance Level
- SNWV N/A
- CYRX $7.89
- Average True Range (ATR)
- SNWV 0.00
- CYRX 0.42
- MACD
- SNWV 0.00
- CYRX -0.05
- Stochastic Oscillator
- SNWV 0.00
- CYRX 32.57
About SNWV SANUWAVE HEALTH INC
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.